產(chǎn)品展示
- 重組人腫瘤生長(zhǎng)相關(guān)因子-γ Recombinant Human GRO-γ(CXCL3) 300-402ug/10ug/Peprotech時(shí)間:2015-11-25型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1666
- 重組人腫瘤生長(zhǎng)相關(guān)因子-γ Recombinant Human GRO-γ(CXCL3) 300-402ug/10ug/Peprotech時(shí)間:2015-11-20型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1308
- 重組人腫瘤生長(zhǎng)相關(guān)因子-γ Recombinant Human GRO-γ(CXCL3) 300-402ug/10ug/Peprotech時(shí)間:2015-11-19型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1374
- 重組人腫瘤生長(zhǎng)相關(guān)因子-β Recombinant Human GRO-β(CXCL2)300-392ug/10ug/Peprotech時(shí)間:2015-11-16型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1409
- 重組人腫瘤生長(zhǎng)相關(guān)因子-β Recombinant Human GRO-β(CXCL2)300-392ug/10ug/Peprotech時(shí)間:2015-11-16型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1287
- 重組人腫瘤生長(zhǎng)相關(guān)因子-β Recombinant Human GRO-β(CXCL2)300-392ug/10ug/Peprotech時(shí)間:2015-11-19型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1591
- 重組人腫瘤生長(zhǎng)相關(guān)因子-β Recombinant Human GRO-β(CXCL2)300-392ug/10ug/Peprotech時(shí)間:2015-11-17型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1278
- 重組人腫瘤生長(zhǎng)相關(guān)因子Recombinant Human GRO/MGSA(CXCL1)300-115ug/25ug/Peprotech時(shí)間:2015-11-21型號(hào):廠商性質(zhì):經(jīng)銷商瀏覽量:1501